15th Annual Conference of the National Foundation for Infectious Diseases (NFID) May 6, 2012

The 15th annual NFID conference will highlight current reports of scientific progress devoted exclusively to research on vaccines and associated technologies for disease prevention and treatment through immunization. The event will feature various symposia and panel discussions associated with vaccine development, production, and distribution.

MedImmune will present:
•"Live Attenuated Influenza Vaccine Stimulates Nasal IgA Responses in Children That Correlate with Protection From Influenza Illness”
•"Do Influenza Illness Symptoms Differ Among Vaccinated And Unvaccinated Children?”
•"Interoffice Variability in the Delivery of Influenza Vaccine by US Pediatric Offices”
•"Does Live Attenuated Influenza Vaccine Reduce All-Cause Acute Otitis Media in Children?”
•"A post-licensure evaluation of the safety of live attenuated influenza vaccine in U.S. children 5-17 years of age”
•"Smaller Pediatric Offices Have Higher In-Office Influenza Vaccination Rates”
•"A Postlicensure Evaluation of the Safety of Live Attenuated Influenza Vaccine in Children 2 to 4 Years of Age”